Stories

2021 Updates: Lilly's Global COVID-19 Response

View Story

Your COVID-19 Treatment Journey: Our Antibodies Might Help

View Story

2020 Updates: Lilly's Global COVID-19 Response

View Story

Lilly's COVID-19 Science Leads to a Second FDA Emergency Use Authorization

View Story

When the World Called for Help with COVID-19, We Were Ready

View Story

Dave Ricks Shares About Lilly's FDA Emergency Use Authorization for a Neutralizing Antibody

View Story

An Update on Lilly’s Commitment to Quality Manufacturing

View Story

CEO Dave Ricks Shares Lilly's Principles of COVID-19 Antibody Therapy Pricing and Access

View Story

Lilly Statement Regarding NIH’s ACTIV-3 Clinical Trial

View Story

Lilly’s Commitment to Quality Manufacturing

View Story